Advertisement

Advertisement

2018 ASH Annual Meeting

Advertisement

Advertisement



May
23
Today In Oncology
Risk of Breast Cancer Among Transgender People
Prostate-Only vs Whole-Pelvis Radiotherapy in Gleason Grade 5 Prostate Cancer
Factors Associated With Major Adverse Cardiovascular Events in Survivors of Colorectal Cancer
IMmotion151: First-Line Atezolizumab/Bevacizumab vs Sunitinib in Metastatic Renal Cell Carcinoma
OPTIMISMM: Addition of Pomalidomide to Bortezomib/Dexamethasone in Pretreated Relapsed or Refractory Multiple Myeloma
View More 
;
Advertisement
Most Read Stories
Tumor Mutational Burden as a Marker of Response to Immunotherapy in MSI-High Metastatic Colorectal Cancer
2019 ASCO: Reduced Chemotherapy Dosages in Elderly Patients With Advanced Gastroesophageal Cancer
Fallopian Tube Removal May Protect Premenopausal Women at High Risk for Ovarian Cancer From Some Surgical Side Effects
Control Arm Quality in Randomized Oncology Trials Leading to FDA Approval
Rate of 'Textbook Outcomes' in Curative-Intent Resection of Intrahepatic Cholangiocarcinoma
View More 
Most Viewed Videos
Jeffrey A. Meyerhardt, MD, MPH, on Colon Cancer: Results From the ACTS-CC 02 Trial on Adjuvant Chemotherapy
Pieter Tanis, MD, PhD, on Colon Cancer: Results From the COLOPEC Trial on Adjuvant HIPEC
Sagar Lonial, MD, on Multiple Myeloma: Sequencing Therapies
Robert A. Figlin, MD, on RCC: Results From the ADAPT Trial
Rowan T. Chlebowski, MD, PhD, on Diet and Breast Cancer: Trial Results
View More 
© 2019 HSP News Service, L.L.C.